发明名称 ESTROGEN RECEPTOR SELECTIVE MODULATORS IN COMBINATION WITH ESTROGEN
摘要 FIELD: medicine. ^ SUBSTANCE: injection is carried out, in therapeutically effective dose, of estrogen, or its prodrug, or mixed estrogen/androgen compound, in some cases, combined with estrogen receptor selective modulator (ERSM). As ERSM compounds of similar structure are applied, where: R1 and R2 are chosen from hydrogen, hydroxyl, or radical that in vivo is converted to hydroxyl; Z is none or chosen from -CH2-, -O-, -S-, and -NR3-; R100 is bivalent radical of 4 to 10 intermediate atoms; L is chosen from -SO-, -CON-, -N<, and -SON<; G1 is chosen from hydrogen, C1-C5-hydrocarbon, radical that together with G2 and L forms 5-7-membered heterocyclic ring, and halogen or unsaturated derivatives of previous substitute; G3 is chosen from hydrogen, methyl, and ethyl. In some versions the above treatment is complemented by androgen agents or biphosphonates administering. ^ EFFECT: effective therapy of diseases mentioned, due to increased action of estrogen receptor selective modulator, combined with lowering estrogen negative action on the organism tissues. ^ 19 cl, 25 dwg, 16 tbl, 12 ex
申请公布号 RU2342145(C2) 申请公布日期 2008.12.27
申请号 RU20020123047 申请日期 2001.01.26
申请人 ANDORESHERSH, INK. 发明人 LABRI FERNAN
分类号 A61K31/565;A61K45/00;A61K31/138;A61K31/192;A61K31/35;A61K31/40;A61K31/453;A61K31/566;A61K31/568;A61K31/5685;A61K31/663;A61K45/06;A61P3/04;A61P3/06;A61P3/12;A61P5/24;A61P5/30;A61P9/10;A61P15/12;A61P19/10;A61P21/00;A61P25/28;A61P43/00 主分类号 A61K31/565
代理机构 代理人
主权项
地址